Vivos Therapeutics Inc. logo

Vivos Therapeutics Inc.

VVOS | NASDAQ
Chart Builder DCF Calculator
$0.50
-$0.01 (-2.19%)
Jun 18, 2026, 4:00 PM ET · Market open

Market Data

Market Cap
$3.21M
Enterprise Value
$12.68M
Beta
6.08
Average Volume
227.35K
Shares Outstanding (Diluted)
14.63M
Shares Change YoY
70.26%
Institutional Ownership
6.00%
Exchange
NASDAQ
ISIN
US92859E2072

Price Performance

Price Change 1M
-19.4%
Price Change 3M
-59.0%
Price Change 6M
-75.6%
Price Change YTD
-80.2%
Price Change 1Y
-79.8%
Price Change 3Y
-95.9%
Price Change 5Y
-99.6%
1M CAGR (ann.)
-27.9%
1Y CAGR (ann.)
-77.1%
5Y CAGR (ann.)
-67.8%
All-Time CAGR
-66.8%

Valuation

PE Ratio
-0.22
Forward PE
N/A
PEG Ratio
0.02
Forward PEG
N/A
PS Ratio
0.15
Forward PS
0.10
PB Ratio
-2.59
P/FCF Ratio
-0.16
P/Adj. FCF Ratio
-0.16
P/OCF Ratio
-0.42
EV/Sales
0.65
EV/EBIT
-0.79
EV/EBITDA
-0.57
EV/FCF
-0.70
Earnings Yield
-460.0%
FCF Yield
-619.7%
Adj. FCF Yield
-636.5%

Financial Health

Net Debt
$9.74M
Total Debt
$11.85M
Cash & Short-Term Investments
$2.11M
Total Assets
$25.04M
Current Ratio
0.27
Quick Ratio
0.27
Debt / Equity Ratio
-10.78
Debt / EBITDA
-0.54
Debt / FCF
-0.65
OCF / Debt
-1.47
Interest Coverage
0.00
Altman Z-Score
-9.32
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
59.5%
Operating Profit Margin
-113.2%
EBITDA Margin
-120.3%
Net Profit Margin
-128.4%
FCF Margin
-93.3%
Adj. FCF Margin
-95.8%
SBC / Revenue
2.5%
SBC Impact (per share)
-2.7%

Returns

Return on Assets
-100.3%
Return on Equity
-2239.2%
Return on Invested Capital
-148.6%
Return on Capital Employed
-318.0%
Return on Tangible Assets
-198.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
2.9%
Revenue CAGR 5Y
6.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
30.7%
EPS CAGR 5Y
18.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
4.7%
FCF CAGR 5Y
-40.7%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Aug 17, 2026
EPS Estimate (next Q)
-$0.42
EPS Growth Est (next Q)
-23.6%
Revenue Est (next Q)
$5.57M
Revenue Growth Est (next Q)
45.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$2.13
Price Target Upside
326.0%

Cash Flow

Operating Cash Flow
$-17.48M
Free Cash Flow
$-18.25M
Adj. Free Cash Flow
$-18.74M
FCF Per Share
-$1.25
OCF Per Share
-$1.19
OCF/S Ratio
-89.3%

Income Statement

Revenue
$19.57M
Gross Profit
$12.09M
Operating Income
$-22.14M
EBITDA
$-22.15M
Net Income
$-25.05M
EPS (Diluted)
-$2.30
Revenue / Employee
$179.52K
Profit / Employee
$-229.81K
Employees
109

© 2026 bestshares.com. All rights reserved.